NOX5 and diabetic kidney disease: A study showed that the overexpression of miR-485 in human mesangial cells alleviated the high glucose (HG)-induced production of ROS and MDA, upregulated SOD, and attenuated inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting Nox5 [210].